Vaccination is one of the world's most effective public health interventions, preventing up to three million deaths globally every year. However, in England, uptake rates for routine childhood immunisations are falling. For measles, mumps, and rubella (MMR), uptake is now below the 95% recommended by the World Health Organisation (WHO), diminishing herd immunity and leading to a resurgence in preventable diseases like measles.
This decline is not uniform; it is significantly more pronounced in areas of high deprivation, exacerbating health inequalities.
For one of the country's most deprived and diverse Integrated Care Boards (ICBs), these challenges are particularly acute. Serving a population of 1.26 million people, childhood immunisation rates are consistently below the national average and continue to fall. In one area alone, over 7,000 children under the age of six were not fully vaccinated.
GP practices are under pressure to improve these rates. While practices receive lists of children who are overdue for vaccination, these are often sent to a generic inbox that is not consistently monitored. Faced with high workloads and limited administrative resources, practice staff lack the time to do more than send a standard text message, which has a limited impact on uptake.
Most significantly, they lack the capacity for the time-consuming, sensitive conversations needed to address vaccine hesitancy, which is a notable barrier, particularly among parents of young children. Without a new approach, vulnerable children remain at risk from preventable diseases.
To address this public health challenge, the ICB commissioned CHASE to design and implement an innovative, collaborative, and patient-centric support service. The project provides GP practices with an enhanced patient identification and recall service focused on the entire routine childhood immunisation schedule for under-5s, with a priority focus on MMR. The service is delivered remotely by a dedicated team of CHASE Primary Care Immunisation Facilitators (PCIFs). This skilled resource is available to practices free of charge, as the programme is fully funded by the ICB.
Key elements of the solution include:
While the 12-month project is still in its early stages, it has already started to deliver impressive results, demonstrating an urgent need for this type of support.
By blending a person-centred approach with innovative technology and collaborative working, this project is proving to be an effective model for tackling one of public health's most pressing challenges. Even a 10-15% uplift in childhood vaccination rates represents a big win, helping to restore vital herd immunity, protect the community, and enable practices to achieve crucial quality and performance targets. The project is also proving helpful in supporting the correct coding of vaccinations, thereby maximising Item of Service (IOS) payments and improving QOF figures.
Take a look through our other case studies in the life-sciences industry.